Ys Biopharma Co Stock Market Value

YS Stock   0.74  0.01  1.37%   
YS Biopharma's market value is the price at which a share of YS Biopharma trades on a public exchange. It measures the collective expectations of YS Biopharma Co investors about its performance. YS Biopharma is selling for under 0.74 as of the 23rd of April 2024; that is 1.37 percent up since the beginning of the trading day. The stock's lowest day price was 0.71.
With this module, you can estimate the performance of a buy and hold strategy of YS Biopharma Co and determine expected loss or profit from investing in YS Biopharma over a given investment horizon. Check out YS Biopharma Correlation, YS Biopharma Volatility and YS Biopharma Alpha and Beta module to complement your research on YS Biopharma.
Symbol

Is YS Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of YS Biopharma. If investors know YS Biopharma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about YS Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of YS Biopharma is measured differently than its book value, which is the value of YS Biopharma that is recorded on the company's balance sheet. Investors also form their own opinion of YS Biopharma's value that differs from its market value or its book value, called intrinsic value, which is YS Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because YS Biopharma's market value can be influenced by many factors that don't directly affect YS Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between YS Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if YS Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, YS Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

YS Biopharma 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to YS Biopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of YS Biopharma.
0.00
03/24/2024
No Change 0.00  0.0 
In 31 days
04/23/2024
0.00
If you would invest  0.00  in YS Biopharma on March 24, 2024 and sell it all today you would earn a total of 0.00 from holding YS Biopharma Co or generate 0.0% return on investment in YS Biopharma over 30 days. YS Biopharma is related to or competes with Revelation Biosciences, Cardio Diagnostics, Biodexa Pharmaceticals, ZyVersa Therapeutics, Sonnet Biotherapeutics, Allarity Therapeutics, and Immix Biopharma. More

YS Biopharma Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure YS Biopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess YS Biopharma Co upside and downside potential and time the market with a certain degree of confidence.

YS Biopharma Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for YS Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as YS Biopharma's standard deviation. In reality, there are many statistical measures that can use YS Biopharma historical prices to predict the future YS Biopharma's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of YS Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.040.807.83
Details
Intrinsic
Valuation
LowRealHigh
0.091.798.82
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as YS Biopharma. Your research has to be compared to or analyzed against YS Biopharma's peers to derive any actionable benefits. When done correctly, YS Biopharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in YS Biopharma.

YS Biopharma Backtested Returns

YS Biopharma appears to be dangerous, given 3 months investment horizon. YS Biopharma retains Efficiency (Sharpe Ratio) of 0.13, which attests that the company had a 0.13% return per unit of price deviation over the last 3 months. By evaluating YS Biopharma's technical indicators, you can evaluate if the expected return of 0.9% is justified by implied risk. Please utilize YS Biopharma's market risk adjusted performance of (1.73), and Standard Deviation of 7.03 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, YS Biopharma holds a performance score of 9. The firm owns a Beta (Systematic Risk) of -0.51, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning YS Biopharma are expected to decrease at a much lower rate. During the bear market, YS Biopharma is likely to outperform the market. Please check YS Biopharma's treynor ratio, expected short fall, and the relationship between the jensen alpha and potential upside , to make a quick decision on whether YS Biopharma's current price history will revert.

Auto-correlation

    
  -0.19  

Insignificant reverse predictability

YS Biopharma Co has insignificant reverse predictability. Overlapping area represents the amount of predictability between YS Biopharma time series from 24th of March 2024 to 8th of April 2024 and 8th of April 2024 to 23rd of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of YS Biopharma price movement. The serial correlation of -0.19 indicates that over 19.0% of current YS Biopharma price fluctuation can be explain by its past prices.
Correlation Coefficient-0.19
Spearman Rank Test-0.19
Residual Average0.0
Price Variance0.0

YS Biopharma lagged returns against current returns

Autocorrelation, which is YS Biopharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting YS Biopharma's stock expected returns. We can calculate the autocorrelation of YS Biopharma returns to help us make a trade decision. For example, suppose you find that YS Biopharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

YS Biopharma regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If YS Biopharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if YS Biopharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in YS Biopharma stock over time.
   Current vs Lagged Prices   
       Timeline  

YS Biopharma Lagged Returns

When evaluating YS Biopharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of YS Biopharma stock have on its future price. YS Biopharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, YS Biopharma autocorrelation shows the relationship between YS Biopharma stock current value and its past values and can show if there is a momentum factor associated with investing in YS Biopharma Co.
   Regressed Prices   
       Timeline  

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards YS Biopharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, YS Biopharma's short interest history, or implied volatility extrapolated from YS Biopharma options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether YS Biopharma is a strong investment it is important to analyze YS Biopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact YS Biopharma's future performance. For an informed investment choice regarding YS Biopharma Stock, refer to the following important reports:
Check out YS Biopharma Correlation, YS Biopharma Volatility and YS Biopharma Alpha and Beta module to complement your research on YS Biopharma.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for YS Biopharma Stock analysis

When running YS Biopharma's price analysis, check to measure YS Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy YS Biopharma is operating at the current time. Most of YS Biopharma's value examination focuses on studying past and present price action to predict the probability of YS Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move YS Biopharma's price. Additionally, you may evaluate how the addition of YS Biopharma to your portfolios can decrease your overall portfolio volatility.
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
YS Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of YS Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of YS Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...